NAYA.O Overview

Penny Stocks to Watch: NAYA Biosciences (now INVO Fertility), WW International, and Nvni Group Ltd. are highlighted as top penny stocks on May 1, 2025, based on their high Dollar Volume and recent performance, with NAYA reporting significant revenue growth after restructuring.

Market Movements: WW International's stock surged over 413% following a partnership with Eli Lilly for weight-loss drug access, while Nvni Group's shares rose significantly despite facing a Nasdaq delisting notice, indicating strong investor interest in these companies.

Company Name Change and New Trading Symbol: INVO Fertility, Inc., formerly NAYA Biosciences, will begin trading under the new Nasdaq symbol "IVF" on April 28, 2025, following a strategic decision to separate its fertility and oncology businesses.

Focus on Fertility Services: The company aims to expand access to advanced reproductive technologies through the establishment and operation of fertility clinics, emphasizing innovative services like the intravaginal culture (IVC) procedure using their proprietary INVOcell device.

Ericsson's Financial Performance: Shares of Ericsson rose 6.9% in pre-market trading after the company reported a 44% increase in adjusted operating earnings and a 3% rise in net sales for the first quarter.

Stock Movements: Various stocks experienced significant changes in pre-market trading, with Splash Beverage Group surging 99.2% and DiaMedica Therapeutics falling 52%.

Company Rebranding and Strategic Separation: INVO Fertility, previously known as NAYA Biosciences, has announced a strategic separation of its fertility and oncology businesses, with the public company rebranding to INVO Fertility, Inc. and changing its Nasdaq ticker from NAYA to IVF effective April 14.

Focus on Fertility Operations: The restructuring will allow INVO Fertility to concentrate on expanding its fertility clinic operations and managing revenue-generating centers while divesting majority ownership in its subsidiary, NAYA Therapeutics, which will operate as a private entity focusing on developing bifunctional antibodies.

Company Name Change and Focus: INVO Fertility, Inc., formerly NAYA Biosciences, will concentrate on building and operating fertility clinics and distributing the FDA-cleared INVOcell device, following a strategic separation from its oncology operations.

NAYA Therapeutics Transition: The subsidiary NAYA Therapeutics will operate as a private company focusing on the clinical development of bifunctional antibodies, while INVO Fertility aims to expand its presence in the fertility market.